OM
Opaleye Management’s Neurogene NGNE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-575,000
| Closed | -$368K | – | 45 |
|
2022
Q3 | $368K | Sell |
575,000
-35,000
| -6% | -$22.4K | 0.15% | 38 |
|
2022
Q2 | $628K | Sell |
610,000
-180,000
| -23% | -$185K | 0.28% | 38 |
|
2022
Q1 | $1.49M | Sell |
790,000
-257,300
| -25% | -$484K | 0.46% | 35 |
|
2021
Q4 | $5.05M | Hold |
1,047,300
| – | – | 1.07% | 29 |
|
2021
Q3 | $7.57M | Sell |
1,047,300
-108,900
| -9% | -$787K | 1.41% | 23 |
|
2021
Q2 | $10.7M | Sell |
1,156,200
-68,800
| -6% | -$635K | 1.77% | 17 |
|
2021
Q1 | $15.1M | Sell |
1,225,000
-161,300
| -12% | -$1.99M | 2.22% | 13 |
|
2020
Q4 | $19.5M | Hold |
1,386,300
| – | – | 2.55% | 13 |
|
2020
Q3 | $16.6M | Sell |
1,386,300
-13,700
| -1% | -$164K | 3.25% | 7 |
|
2020
Q2 | $23.2M | Hold |
1,400,000
| – | – | 4.69% | 3 |
|
2020
Q1 | $15.9M | Buy |
1,400,000
+18,700
| +1% | +$213K | 4.22% | 5 |
|
2019
Q4 | $17M | Buy |
1,381,300
+386,300
| +39% | +$4.76M | 3.34% | 11 |
|
2019
Q3 | $2.84M | Buy |
+995,000
| New | +$2.84M | 1.03% | 34 |
|
2017
Q2 | – | Sell |
-85,000
| Closed | -$1.42M | – | 46 |
|
2017
Q1 | $1.42M | Sell |
85,000
-225,000
| -73% | -$3.75M | 0.71% | 34 |
|
2016
Q4 | $5.12M | Hold |
310,000
| – | – | 3.02% | 10 |
|
2016
Q3 | $4.14M | Buy |
310,000
+15,000
| +5% | +$200K | 2.17% | 18 |
|
2016
Q2 | $1.95M | Buy |
+295,000
| New | +$1.95M | 1.3% | 30 |
|